Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.

The endocrine and therapeutic effects of the aromatase inhibitor fadrozole hydrochloride have been assessed in 80 post-menopausal patients with recurrent breast cancer after tamoxifen failure. Treatment allocation was randomly 0.5, 1.0 or 2.0 mg orally b.d. Eight patients were not assessable for res...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bonnefoi, H. R., Smith, I. E., Dowsett, M., Trunet, P. F., Houston, S. J., da Luz, R. J., Rubens, R. D., Coombes, R. C., Powles, T. J.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1996
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2074462/
https://ncbi.nlm.nih.gov/pubmed/8595171
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki